GENE ONLINE|News &
Opinion
Blog

2026-04-07|

ZEO ScientifiX Advances to Semi-Finals of XPRIZE Healthspan Competition

by GOAI
Share To

ZEO ScientifiX has been selected as a qualified team advancing to the semi-finals stage of the XPRIZE Healthspan competition. The announcement confirms the company’s inclusion among teams progressing in the global contest, which aims to accelerate breakthroughs in extending human healthspan and improving quality of life during aging.

The XPRIZE Healthspan competition challenges participants to develop innovative solutions that enhance longevity and health outcomes. ZEO ScientifiX, listed on OTCQB under the ticker symbol ZEOX, is now positioned to compete further in this initiative. Teams selected for the semi-finals undergo rigorous evaluation based on their proposed methodologies, scientific approaches, and potential impact on human health. This advancement signifies recognition of ZEO ScientifiX’s efforts within this competitive field. Further updates regarding subsequent stages are expected as the competition progresses.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 7, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Study Finds Non-Communicable Diseases Consume Large Portion of Household Income Among Elderly in India
2026-04-19
Study Identifies Antiviral Compounds in Egyptian Ziziphus spina-christi Effective Against Respiratory Viruses
2026-04-19
10x Genomics Introduces Atera Platform for Single-Cell Analysis and Spatial Biology
2026-04-18
Elevated Fetal Catecholamine Metabolites Linked to Growth Restriction in Sheep Model Study
2026-04-18
White House Issues Executive Order to Boost Research and Access to Psychedelic-Based Mental Health Therapies
2026-04-18
Comorbidities Linked to Higher Risks and Complications in Hip Fracture Surgery Outcomes
2026-04-18
20-Year Study Links Metabolically Healthy Obesity to Increased Long-Term Cardiovascular Disease Risk
2026-04-18
Scroll to Top